3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid,
4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid,
cppene,
D-CPP-ene,
SDZ EAA 494,
SDZ EAA 494, (E)-isomer,
SDZ EAA 494, (R-(E))-isomer,
SDZ EAA 494, (S-(E))-isomer,
Midafotel,
D-Cpp-ene,
117414-74-1,
UNII-7LYU6ZF84G,
SDZ-EAA 494,
7LYU6ZF84G,
NCGC00092278-02,
2-Piperazinecarboxylic acid, 4-[(2E)-3-phosphono-2-propenyl]-, (2R)-,
D-4-[(2E)-3-PHOSPHONO-2-PROPENYL]-2-PIPERAZINECARBOXYLIC ACID,
(R,E)-4-(3-Phosphonoallyl)piperazine-2-carboxylic acid,
C16H25N5O2,
(-)-(R)-4-((E)-3-Phosphonoallyl)-2-piperazinecarboxylic acid,
Midafotel [INN],
SDZ-EAA-494,
d-cppene,
AC1O5KHY,
DSSTox_CID_25740,
DSSTox_RID_81085,
DSSTox_GSID_45740,
CHEMBL90564,
SDZ EAA-494,
SCHEMBL1061150,
SCHEMBL1061155,
DTXSID1045740,
Tox21_111189,
ZINC22441635,
AKOS024456500,
SDZ EAA 494, (R-(E))-isomer,
NCGC00092278-01,
CC-26225,
LS-172352,
B6665,
CAS-117414-74-1,
(2R)-4-[(E)-3-phosphonoprop-2-enyl]piperazine-2-carboxylic acid,
[2R,(?)]-4-(3-Phosphono-2-propenyl)-2-piperazinecarboxylic acid,
2-Piperazinecarboxylicacid,4-[(2E)-3-phosphono-2-propenyl]-,(2R)-,
Sdz eaa 494,
D0HK7R,
EAA-494,
C8-H15-N2-O5-P,
CID6435801,